Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial
Titel:
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial
Auteur:
Izutsu, Koji Kumode, Takahiro Yuda, Junichiro Nagai, Hirokazu Mishima, Yuko Suehiro, Youko Yamamoto, Kazuhito Fujisaki, Tomoaki Ishitsuka, Kenji Ishizawa, Kenichi Ikezoe, Takayuki Nishikori, Momoko Akahane, Daigo Fujita, Jiro Jafarinasabian, Pegah Soong, David D’Angelo Månsson, Barbara Takahashi, Ami Favaro, Elena Fukuhara, Noriko